Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Ruining Biotechnology

Request full access

Medical hydrogel products for oncology and intervention

ChinaFounded 2018Health Tech & Medtech

About Shanghai Ruining Biotechnology

Shanghai Ruining Biotechnology Co., Ltd. (Reunion Biotech) is a high-tech enterprise focused on the research, development, and commercialization of high-end biomedical materials. The company was founded by PhDs who returned from overseas and is dedicated to bringing advanced biomaterials to market. Reunion Biotech has developed a leading medical hydrogel technology platform to create medical device solutions for oncology. A key feature is its proprietary "ready-to-use" polyethylene glycol (PEG) hydrogel platform.

The company's product pipeline includes innovative Class III medical devices designed for minimally invasive treatments through implantation and intervention. These solutions address clinical needs such as tumor radiotherapy protection, wound repair, and tumor embolization. For instance, its Radiotherapy Hydrogel Spacer is a solution-stable, "ready-to-use" formulation. In early 2026, the company's tumor "Embolization Hydrogel" was accepted into the National Innovative Medical Device "Green Channel," a significant milestone.

Reunion Biotech operates from a facility of over 4,000 square meters, which includes a Research & Development center, GMP (Good Manufacturing Practice) facilities, and laboratories for physical, chemical, and microbiological testing. The company has secured hundreds of millions of RMB in investment from notable venture capital firms, including Qiming Venture Capital. It collaborates with universities, research institutes, and top-tier hospitals to drive product innovation. In recognition of its intellectual property management and commercialization capabilities, the Shanghai Intellectual Property Bureau named Reunion Bio a “Shanghai Patent Work Demonstration Enterprise” for 2025.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
21.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Oncology, medical implants, Surgery, Advanced Materials, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Feb 2026 $14M $55M Qiming Venture Partners ↗
SERIES B✓Equity / VC Jan 2024 $14M $55M Dingxin Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Ruining Biotechnology website traffic

Latest recorded traffic for Shanghai Ruining Biotechnology is 160 monthly website visits.

Latest monthly visits160
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Ruining Biotechnology in its local ecosystem

Live from Dealroom

The Shanghai Ruining Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Ruining Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Ruining Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.